Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Seefat MR"'
Autor:
Smits F; Amsterdam UMC, Amsterdam, Netherlands., Groen K; Amsterdam UMC, Amsterdam, Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht, the Netherlands., Dordrecht, Netherlands., Stege C; Erasmus Medical Center, Rotterdam, Netherlands., van Kampen RJW; Zuyerland Medical Center, Sittard-Geleen, Netherlands., van der Spek E; Rijnstate, Doorn, Netherlands., Bilgin YM; ADRZ, Goes, Netherlands., Thielen N; Diakonessenhuis, Utrecht, Netherlands., Nijhof IS; St Antonius Ziekenhuis, Nieuwegein, Netherlands., Ludwig I; Bernhoven Hospital, Uden, Netherlands., de Waal EGM; Medical Center Leeuwarden, Leeuwarden, Netherlands., Sandberg Y; Maasstad Hospital, Rotterdam, Netherlands., Kentos A; Centre Hospitalier Jolimont, Haine-Saint-Paul, Belgium., Timmers GJ; Amstelland Hospital, Amstelveen, Netherlands., Regelink JC; Meander Medical Center, Amersfoort, Netherlands., Westerman M; Northwest Clinics, Alkmaar, Netherlands., Heer K; Flevoziekenhuis, Almere, Netherlands., Vekemans MM; UCL Cliniques universitaires Saint-Luc, Brussels, Belgium., Durdu-Rayman N; Franciscus Hospital, location Vlietland, Schiedam, Netherlands., de Graauw NCHP; Bravis Hospital, Roosendaal, Netherlands., Seefat MR; Amsterdam UMC, Amsterdam, Netherlands., van de Donk NWCJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Ypma PF; Haga Hospital, The Hague, Netherlands., Nasserinejad K; ErasmusMC University, Rotterdam, Netherlands., Zweegman S; Amsterdam UMC. Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
Publikováno v:
Blood [Blood] 2024 Nov 22. Date of Electronic Publication: 2024 Nov 22.
Autor:
Abdullah-Koolmees H; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. h.abdullah1@amsterdamumc.nl., van den Nieuwendijk JF; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Hoope SMKT; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., de Leeuw DC; Department of Haematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Franken LGW; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Said MM; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Seefat MR; Department of Haematology, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Swart EL; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands., Hendrikse NH; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC location VUmc, The Netherlands, Amsterdam.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bartelink IH; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC Location Vrije Universiteit Amsterdam, Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands. i.bartelink@amsterdamumc.nl.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2024 Nov; Vol. 49 (6), pp. 689-699. Date of Electronic Publication: 2024 Sep 14.
Autor:
Seefat MR; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī., Stege CAM; Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlandsī., Lissenberg-Witte BI; Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Levin MD; Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Timmers GJ; Internal Medicine, Amstelland Hospital, Amstelveen, the Netherlands., Hoogendoorn M; Hematology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Ypma PF; Hematology, Haga Hospital, Den Haag, the Netherlands., Klein SK; Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands; Department of Internal Medicine, Meander Medical Center, Amersfoort, the Netherlands., Velders GA; Internal Medicine, Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Westerman M; Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands., Strobbe L; Internal Medicine, Gelre Hospital Zutphen, Zutphen, the Netherlands., Durdu-Rayman N; Internal Medicine, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., Davidis-van Schoonhoven MA; Internal Medicine, Beatrix Hospital, Gorinchem, the Netherlands., van Kampen RJW; Internal Medicine-hematology, Zuyderland Medical Center, Sittard-Geleen, the Netherlands., Dijk AC; Internal Medicine, St Jansdal Hospital, Harderwijk, the Netherlands., Koster A; Internal Medicine, Viecuri Medical Center, Venlo, the Netherlands., Silbermann MH; Internal Medicine, Tergooi Hospital, Hilversum, the Netherlands., van der Spek E; Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., Beeker A; Internal Medicine, MBA Spaarne Gasthuis, Hoofddorp, the Netherlands., Erjavec Z; Internal Medicine, Treant ziekenhuis, Hoogeveen, the Netherlands., de Graauw NCHP; Internal Medicine, Bravis ziekenhuis, Roosendaal, the Netherlands., Leys MBL; Hematology and Oncology, Maasstad ziekenhuis, Rotterdam, the Netherlands., Sonneveld P; Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlandsī., van de Donk NWCJ; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī., Nasserinejad K; Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlandsī., Blommestein HM; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, the Netherlands., Cucchi DGJ; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī; Internal Medicine, Franciscus Hospital location Vlietland, Schiedam, the Netherlands., Zweegman S; Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlandsī. Electronic address: s.zweegman@amsterdamumc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114153. Date of Electronic Publication: 2024 Jun 06.
Autor:
Groen K; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Smits F; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Nasserinejad K; HOVON Foundation Rotterdam The Netherlands.; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Levin MD; Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands., Regelink JC; Department of Internal Medicine Meander Medical Centre Amersfoort The Netherlands., Timmers GJ; Department of Internal Medicine Amstelland Hospital Amstelveen The Netherlands., de Waal EGM; Department of Internal Medicine Medical Centre Leeuwarden Leeuwarden The Netherlands., Westerman M; Department of Internal Medicine Northwest Clinics Alkmaar The Netherlands., Velders GA; Department of Internal Medicine Gelderse Vallei Ede The Netherlands., de Heer K; Department of Internal Medicine Flevoziekenhuis Almere The Netherlands., Leys RBL; Department of Internal Medicine Maasstad Hospital Rotterdam The Netherlands., van Kampen RJW; Department of Internal Medicine Zuyderland Hospital Sittard-Geleen The Netherlands., Stege CAM; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands.; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands., Seefat MR; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Nijhof IS; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Department of Internal Medicine Antonius Ziekenhuis Nieuwegein The Netherlands., van der Spek E; Department of Internal Medicine Rijnstate Hospital Arnhem The Netherlands., Klein SK; Department of Internal Medicine Meander Medical Centre Amersfoort The Netherlands.; Department of Hematology University Medical Center Groningen Groningen The Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands., Ypma PF; Department of Hematology Hagaziekenhuis, Den Haag The Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC Vrije Universiteit Amsterdam The Netherlands.; Cancer Center Amsterdam, Treatment and Quality of life Amsterdam The Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2024 Jul 04; Vol. 8 (7), pp. e85. Date of Electronic Publication: 2024 Jul 04 (Print Publication: 2024).
Autor:
Seefat MR; Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Cucchi DGJ; Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., Groen K; Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Donker ML; Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., van der Hem KG; Department of Internal Medicine, Zaandam Medical Center, Zaandam, The Netherlands., Westerman M; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands., Gerrits AM; Department of Internal Medicine, OLVG, Amsterdam, The Netherlands., Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands., van de Donk NWCJ; Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands., Blommestein HM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Zweegman S; Department of Hematology, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 360-366. Date of Electronic Publication: 2023 Oct 11.
Autor:
Groen K; Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, the Netherlands., Schjesvold FH; Department of Hematology, Oslo Myeloma Center, Oslo University Hospital, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Norway., van der Holt B; Department of Hematology, HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands., Seefat MR; Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, the Netherlands., Hansson M; Department of Hematology, Skåne University Hospital Lund, Sweden., Leys MBL; Department of Internal Medicine, Maasstad Hospital, Rotterdam, the Netherlands., Regelink JC; Department of Internal Medicine, Meander Medical Centre, Amersfoort, the Netherlands., Waage A; Institute of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Szatkowski D; Department of Oncology and Hematology, Førde Central Hospital, Norway., Axelsson P; Department of Internal Medicine, Helsingborg Hospital, Sweden., Hieu Do T; Haematology Department H 60, Roskilde Sjaelland University, Denmark., Svirskaite A; Department of Hematology, Aalborg University Hospital, Denmark., van der Spek E; Department of Internal Medicine, Rijnstate Hospital, Arnhem, the Netherlands., Haukas E; Department for Blood and Cancer Diseases, Stavanger University Hospital, Norway., Knut-Bojanowska D; Institute of Heamatology, Uddevalla Hospital, Sweden., Ypma PF; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Blimark CH; Hematology Department, Sahlgrenska University Hospital, Gothenburg, Sweden., Mellqvist UH; Department of Internal Medicine, Sodra Alvsborgs Sjukhus, Boras, Sweden., van de Donk NWCJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, the Netherlands., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Klostergaard A; Department of Hematology, Aarhus University Hospital, Denmark., Vangsted AJ; Department of Hematology, Rigshospitalet, Copenhagen, Denmark., Abildgaard N; Department of Hematology, Hematology Research Unit and Academy of Geriatric Research, Odense University Hospital and University of Southern Denmark, Denmark., Zweegman S; Department of Hematology, Amsterdam UMC, Vrije Universiteit, the Netherlands.; Cancer Center Amsterdam, Treatment and Quality of Life, the Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2023 Aug 30; Vol. 7 (9), pp. e940. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).
Autor:
Bennink MC; Department of Haematology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Strategy, Amphia Hospital, Breda, the Netherlands., Stege CAM; Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., Lissenberg-Witte BI; Department of Epidemiology and Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, the Netherlands., Oerlemans S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands., Seefat MR; Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands., Sonneveld P; Department of Haematology, Erasmus University Medical Center, Rotterdam, the Netherlands., Zweegman S; Department of Haematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, the Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2022 Jun 21; Vol. 6 (7), pp. e744. Date of Electronic Publication: 2022 Jun 21 (Print Publication: 2022).
Autor:
Seefat MR; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Cucchi DGJ; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Dirven S; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Groen K; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Zweegman S; Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands., Blommestein HM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, 3062 PA Rotterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Nov 09; Vol. 13 (22). Date of Electronic Publication: 2021 Nov 09.